We recently reported 7 a potent and selective N-type calcium channel blocker 1 (Fig. 1) with efficacy in animal pain models when delivered intraperitoneal (ip). Herein we describe the discovery of orally efficacious N-type calcium channel blockers using a set of in vitro high throughput-ADME (HT-ADME) data in conjunction with Ca v 2.2 potency. The HT-ADME data allowed for optimization of pharmacokinetic properties to provide compounds for oral dosing in efficacy studies. ...